Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **Tec family of tyrosine kinases** comprises a group of non-receptor, cytoplasmic protein tyrosine kinases including Tec, Bruton’s tyrosine kinase (BTK), inducible T-cell kinase (Itk), resting lymphocyte kinase (Rlk/Txk), and bone marrow-expressed kinase (Bmx/Etk)[1][3][4][5][8]. These enzymes are defined by a unique domain structure containing a pleckstrin homology (PH) domain, Tec homology (TH) domain, Src homology SH2 and SH3 domains, and a tyrosine kinase catalytic domain[1][3][7][8]. They are primarily expressed in hematopoietic cells (T cells, B cells, NK cells, mast cells) and are crucial for immune cell signaling, especially in antigen receptor signaling pathways[2][4][5][8]. Tec kinases regulate not only activation of phospholipase C-γ but also cytoskeletal reorganization, cellular adhesion, and differentiation[2][5]. Mutations in BTK cause immunodeficiency (XLA), and inhibition of BTK is a validated therapeutic mechanism in B-cell malignancies[6][8]. Other family members have emerging roles in autoimmune and cardiovascular diseases, and the wider family is a target of interest for drug development[4][8].
Inhibition of kinase activity, especially phosphorylation of downstream targets - Blockade of antigen receptor signaling - Modulation of immune cell activation and differentiation - Inhibition of pro-inflammatory cytokine production
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tec family of tyrosine kinases.